BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 29888964)

  • 21. Methylation of α-synuclein and leucine-rich repeat kinase 2 in leukocyte DNA of Parkinson's disease patients.
    Tan YY; Wu L; Zhao ZB; Wang Y; Xiao Q; Liu J; Wang G; Ma JF; Chen SD
    Parkinsonism Relat Disord; 2014 Mar; 20(3):308-13. PubMed ID: 24398085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alteration in the expression of MGMT and RUNX3 due to non-CpG promoter methylation and their correlation with different risk factors in esophageal cancer patients.
    Saikia S; Rehman AU; Barooah P; Sarmah P; Bhattacharyya M; Deka M; Deka M; Goswami B; Husain SA; Medhi S
    Tumour Biol; 2017 May; 39(5):1010428317701630. PubMed ID: 28468586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA methylation at selected CpG sites in peripheral blood leukocytes is predictive of gastric cancer.
    Dauksa A; Gulbinas A; Endzinas Z; Oldenburg J; El-Maarri O
    Anticancer Res; 2014 Oct; 34(10):5381-8. PubMed ID: 25275032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genome-wide DNA methylation profiles altered by Helicobacter pylori in gastric mucosa and blood leukocyte DNA.
    Zhang Y; Zhang XR; Park JL; Kim JH; Zhang L; Ma JL; Liu WD; Deng DJ; You WC; Kim YS; Pan KF
    Oncotarget; 2016 Jun; 7(24):37132-37144. PubMed ID: 27206798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigenomic profiling of DNA methylation in paired prostate cancer versus adjacent benign tissue.
    Geybels MS; Zhao S; Wong CJ; Bibikova M; Klotzle B; Wu M; Ostrander EA; Fan JB; Feng Z; Stanford JL
    Prostate; 2015 Dec; 75(16):1941-50. PubMed ID: 26383847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening for genomic fragments that are methylated specifically in colorectal carcinoma with a methylated MLH1 promoter.
    Koinuma K; Kaneda R; Toyota M; Yamashita Y; Takada S; Choi YL; Wada T; Okada M; Konishi F; Nagai H; Mano H
    Carcinogenesis; 2005 Dec; 26(12):2078-85. PubMed ID: 16033773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Promoter CpG-Site Methylation of the KAI1 Metastasis Suppressor Gene Contributes to Its Epigenetic Repression in Prostate Cancer.
    Lee J; Lee MS; Jeoung DI; Kim YM; Lee H
    Prostate; 2017 Mar; 77(4):350-360. PubMed ID: 27813113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical significance of the methylated cytosine-phosphate-guanine sites of protocadherin-10 promoter for evaluating the prognosis of gastric cancer.
    Deng J; Liang H; Ying G; Dong Q; Zhang L; Yu J; Fan D; Hao X
    J Am Coll Surg; 2014 Nov; 219(5):904-13. PubMed ID: 25260683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypomethylation coordinates antagonistically with hypermethylation in cancer development: a case study of leukemia.
    Kushwaha G; Dozmorov M; Wren JD; Qiu J; Shi H; Xu D
    Hum Genomics; 2016 Jul; 10 Suppl 2(Suppl 2):18. PubMed ID: 27461342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The relationship between gene-specific DNA methylation in leukocytes and normal colorectal mucosa in subjects with and without colorectal tumors.
    Ally MS; Al-Ghnaniem R; Pufulete M
    Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):922-8. PubMed ID: 19258481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation.
    Nguyen CT; Gonzales FA; Jones PA
    Nucleic Acids Res; 2001 Nov; 29(22):4598-606. PubMed ID: 11713309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Promoter CpG island methylation in ion transport mechanisms and associated dietary intakes jointly influence the risk of clear-cell renal cell cancer.
    Deckers IA; van Engeland M; van den Brandt PA; Van Neste L; Soetekouw PM; Aarts MJ; Baldewijns MM; Keszei AP; Schouten LJ
    Int J Epidemiol; 2017 Apr; 46(2):622-631. PubMed ID: 27789672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased CpG methylation of the estrogen receptor gene in BRCA1-linked estrogen receptor-negative breast cancers.
    Archey WB; McEachern KA; Robson M; Offit K; Vaziri SA; Casey G; Borg A; Arrick BA
    Oncogene; 2002 Oct; 21(46):7034-41. PubMed ID: 12370825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Damage-inducible intragenic demethylation of the human TP53 tumor suppressor gene is associated with transcription from an alternative intronic promoter.
    Blackburn J; Roden DL; Ng R; Wu J; Bosman A; Epstein RJ
    Mol Carcinog; 2016 Dec; 55(12):1940-1951. PubMed ID: 26676339
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genome-wide DNA methylation analysis reveals molecular subtypes of pancreatic cancer.
    Mishra NK; Guda C
    Oncotarget; 2017 Apr; 8(17):28990-29012. PubMed ID: 28423671
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methyl-CpG-binding protein MBD2 plays a key role in maintenance and spread of DNA methylation at CpG islands and shores in cancer.
    Stirzaker C; Song JZ; Ng W; Du Q; Armstrong NJ; Locke WJ; Statham AL; French H; Pidsley R; Valdes-Mora F; Zotenko E; Clark SJ
    Oncogene; 2017 Mar; 36(10):1328-1338. PubMed ID: 27593931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PGC1A driven enhanced mitochondrial DNA copy number predicts outcome in pediatric acute myeloid leukemia.
    Chaudhary S; Ganguly S; Palanichamy JK; Singh A; Bakhshi R; Jain A; Chopra A; Bakhshi S
    Mitochondrion; 2021 May; 58():246-254. PubMed ID: 33812061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Age-related methylation profiles of equine blood leukocytes in the RNASEL locus.
    Ząbek T; Semik E; Szmatoła T; Oklejewicz B; Fornal A; Bugno-Poniewierska M
    J Appl Genet; 2016 Aug; 57(3):383-8. PubMed ID: 26553552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Susceptibility of nonpromoter CpG islands to de novo methylation in normal and neoplastic cells.
    Nguyen C; Liang G; Nguyen TT; Tsao-Wei D; Groshen S; Lübbert M; Zhou JH; Benedict WF; Jones PA
    J Natl Cancer Inst; 2001 Oct; 93(19):1465-72. PubMed ID: 11584062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Promoter methylation status of the MGMT, hMLH1, and CDKN2A/p16 genes in non-neoplastic mucosa of patients with and without colorectal adenomas.
    Ye C; Shrubsole MJ; Cai Q; Ness R; Grady WM; Smalley W; Cai H; Washington K; Zheng W
    Oncol Rep; 2006 Aug; 16(2):429-35. PubMed ID: 16820927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.